Trials / Conditions / Resectable Intrahepatic Cholangiocarcinoma

Resectable Intrahepatic Cholangiocarcinoma

4 registered clinical trials studyying Resectable Intrahepatic Cholangiocarcinoma — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Imp NCT06050252	National Cancer Institute (NCI)	Phase 2
Withdrawn	Preoperative Nab-paclitaxel, Cisplatin, and Gemcitabine Chemotherapy With or Without Infigratinib Targeted The NCT05514912	Emory University	Phase 2
Recruiting	Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver Cancer NCT05265208	Center Eugene Marquis	Phase 2
Terminated	A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectabl NCT02256982	Massachusetts General Hospital	N/A